Topchoice Medical Co., Inc. (SHA:600763)
China flag China · Delayed Price · Currency is CNY
35.59
+1.38 (4.03%)
Oct 30, 2026, 3:00 PM CST

Topchoice Medical Co. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
634.11501.95501500.44548.27702.81
Depreciation & Amortization
187.42190.93203.41189.35173.31153.8
Other Amortization
73.7272.564.4555.2546.135
Loss (Gain) From Sale of Assets
0.270.27-0.14-0.050.02
Asset Writedown & Restructuring Costs
0.360.360.860.420.510.21
Loss (Gain) From Sale of Investments
-47.33-47.33-47.84-60.19-38.3-56.13
Provision & Write-off of Bad Debts
11.3511.353.171.751.671.29
Other Operating Activities
67.25122.82114.15131.85117.71109.25
Change in Accounts Receivable
-44.44-42.73-28.94-37.77-45.07-46.88
Change in Inventory
10.1310.22-3.74-1.9-2.55-2.68
Change in Accounts Payable
18.83-3.78-37.371.22-122.1236.97
Change in Other Net Operating Assets
-9.3-1.64-1.64-1.64-1.64-1.64
Operating Cash Flow
898.19810.72762.99841.02670.05939.41
Operating Cash Flow Growth
10.26%6.25%-9.28%25.52%-28.67%32.59%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-205.07-246.2-332.11-508.9-421.53-367.32
Sale of Property, Plant & Equipment
2.092.152.020.010.620.02
Cash Acquisitions
-540-15-27.73---
Divestitures
----0.03-131.95
Investment in Securities
3.3111.11-7.04-504.25-60.45-234.42
Other Investing Activities
-10.64-31.31-96.1-14.47-15.99-14
Investing Cash Flow
-750.31-279.24-324.97-887.63-497.35-483.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-5080280--
Long-Term Debt Repaid
--224.81-252.43-193.57-251.18-241.76
Lease Payments
-124.81-124.81-133.63-151.57-141.18-136.76
Net Debt Issued (Repaid)
46.19-174.81-172.4386.43-251.18-241.76
Repurchase of Common Stock
---30.1-1-99.99-
Common Dividends Paid
--208.89-149.89-11.24-6.69-12.87
Other Financing Activities
-153.59-71.32-59.85-63.04-28.33-31.3
Financing Cash Flow
-107.41-455.02-412.2811.15-386.19-285.93

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
40.4676.4625.74-35.46-213.5169.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
693.11564.52430.88332.13248.52572.09
Free Cash Flow Growth
27.27%31.02%29.73%33.64%-56.56%6.33%
Free Cash Flow Margin
22.73%19.38%14.99%11.67%9.14%20.57%
Free Cash Flow Per Share
1.551.260.960.740.551.27
Levered Free Cash Flow
467.71330.95375.96331.44-199.6365.3
Unlevered Free Cash Flow
470.62353.36404.36365.82-168.32383.37
Free Cash Flow After Leases
568.3439.71297.24180.56107.33435.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
171.98153.52162.07142.52227.01105.67
Change in Working Capital
-28.96-42.12-76.0622.15-179.26-6.83